FDA Approved: NATROBA — Supplemental Application (Cipher Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for NATROBA (spinosad) by Cipher Pharmaceuticals to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pediculosis Capitis

Drugs mentioned

• NATROBA (spinosad)

Snippet

SUPPL AP for NATROBA (SPINOSAD)